2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$40.74-$0.24 (-0.59%)
Price as of Aug 03, 2026 4:12 PM EDT- $2.0BMarket Cap
- 189.61%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$40.74-$0.24 (-0.59%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 14.99% | 7.2M | +57,074 (+0.80%) | Mar 31, 2026 |
TRV GP V, LLC | 14.92% | 7.1M | 0 (0.00%) | Mar 31, 2026 |
ARCH VENTURE MANAGEMENT, LLC | 7.80% | 3.7M | 0 (0.00%) | Mar 31, 2026 |
CAPITAL INTERNATIONAL INVESTORS | 6.48% | 3.1M | -304,556 (-9.83%) | Mar 31, 2026 |
CORMORANT ASSET MANAGEMENT, LP | 6.18% | 3.0M | -70,000 (-2.37%) | Mar 31, 2026 |
GOLDMAN SACHS GROUP INC | 6.15% | 2.9M | -59,628 (-2.03%) | Mar 31, 2026 |
BLACKROCK, INC. | 5.24% | 2.5M | +74,093 (+2.96%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SMALLCAP WORLD FUND INC | 7.60% | 3.6M | +232,051 (+6.38%) | Mar 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 7.38% | 3.5M | +378,373 (+10.72%) | May 31, 2026 |
VANGUARD INDEX FUNDS | 2.70% | 1.3M | +9,242 (+0.71%) | Mar 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 1.26% | 601,105 | -42,329 (-7.04%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.90% | 428,273 | -328,500 (-76.70%) | May 31, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 0.76% | 364,351 | -499 (-0.14%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 0.68% | 324,946 | 0 (0.00%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions265.4M (77.75%)
- Mutual Funds68.0M (19.91%)
- Insiders8.0M (2.35%)
- Other0 (0.00%)
Insider Transactions
- 2.35% (8.0M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $841,885.42Amount of InsiderBuying (last 12 months)
- 4Number of InsiderSelling (last 12 months)
- $510.2MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Ceesay Abraham Chief Executive Officer | Sell | Jul 27, 2026 | $92,761.72 | 2,203 | $42.11 | 537,614 |
Ceesay Abraham Chief Executive Officer | Sell | Jul 27, 2026 | $299.14 | 7 | $42.73 | 537,607 |
Ceesay Abraham Chief Executive Officer | Sell | Jul 14, 2026 | $217,714.64 | 5,481 | $39.72 | 542,546 |
Ceesay Abraham Chief Executive Officer | Sell | Jul 14, 2026 | $110,722.08 | 2,729 | $40.57 | 539,817 |
Ceesay Abraham Chief Executive Officer | Sell | Jun 29, 2026 | $292,062.07 | 7,344 | $39.77 | 548,903 |
Ceesay Abraham Chief Executive Officer | Sell | Jun 29, 2026 | $35,335.65 | 876 | $40.34 | 548,027 |
Huber Reid M | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
Silva Paul M | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
MARAGANORE JOHN | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
Young Wendy B. | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
HEALY JAMES | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
Sanchez Ramiro | Award | Jun 10, 2026 | $0.00 | 15,200 | $0.00 | 15,200 |
Yeleswaram Krishnaswamy Chief Development Officer | Sell | Apr 08, 2026 | $12,564.00 | 360 | $34.90 | 286,516 |
Gault Cheryl Chief Operating Officer | Sell | Mar 30, 2026 | $200,795.16 | 7,161 | $28.04 | 162,753 |
Gault Cheryl Chief Operating Officer | Sell | Mar 30, 2026 | $81,061.97 | 2,839 | $28.55 | 159,914 |
Yeleswaram Krishnaswamy Chief Development Officer | Sell | Mar 25, 2026 | $303,354.92 | 10,115 | $29.99 | 286,876 |
Gault Cheryl Chief Operating Officer | Sell | Mar 05, 2026 | $58,265.02 | 2,014 | $28.93 | 169,914 |
Bredt David Chief Scientific Officer | Exempt | Feb 19, 2026 | $10,800.00 | 6,000 | $1.80 | 393,075 |
Bredt David Chief Scientific Officer | Exempt | Feb 19, 2026 | $0.00 | 6,000 | $0.00 | 88,080 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $103,191.28 | 3,552 | $29.05 | 558,528 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $67,969.92 | 2,281 | $29.80 | 556,247 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $86,639.15 | 2,983 | $29.04 | 22,829 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $62,572.65 | 2,100 | $29.80 | 20,729 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $25,218.99 | 900 | $28.02 | 394,675 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $156,328.38 | 5,400 | $28.95 | 389,275 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $65,107.68 | 2,200 | $29.59 | 387,075 |
Ignelzi Troy A. Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 148,000 | $0.00 | 148,000 |
Sevigny Jeffrey Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 130,000 | $0.00 | 130,000 |
Gault Cheryl Chief Operating Officer | Award | Feb 02, 2026 | $0.00 | 132,000 | $0.00 | 132,000 |
Ceesay Abraham Chief Executive Officer | Award | Feb 02, 2026 | $0.00 | 428,000 | $0.00 | 428,000 |